Our vision of enabling researchers to rapidly move from the lab to life-changing advances reflects our commitment to a healthier, brighter future for all. 🧬
🎗Reminder to the @iGEM community: it’s not too late to order! The last day to order from IDT is October 12. Be sure to check out the free resources we offer to help accelerate your project here: https://t.co/aM3bxOR190
Avoid dead-end workflows when your fragment request hits a limit. With IDT and @AnsaBio, there’s a better path forward. ⏩ Our “No Loose Ends” workflow helps guide complex designs beyond fragment fit—toward fully assembled clonal genes, without losing momentum. 🧬
So when your project gets more ambitious, your workflow doesn’t stall.
Learn more here: https://t.co/I9oY1jlbKe
We're pleased to welcome @idtdna on board as a Silver Sponsor at our 2026 ARC Centre of Excellence in Synthetic Biology (CoESB) Annual Conference! #CoESB26
Integrated DNA Technologies (IDT) is a leading provider of genomics solutions supporting multi-omics research. IDT offers custom nucleic acids, NGS products, CRISPR tools, gene synthesis, and molecular biology reagents that enable researchers to advance genomic, transcriptomic, and other omics workflows, accelerating discoveries in life science and precision medicine.
Thank you for your support! 🙏
@arc_gov_au
CRISPR/Cas9 transformed #genomeediting, but it's no longer the only option. Explore current approaches and key considerations to choosing the right tool with Mollie Schubert, senior innovation product manager at IDT, and Loren Schoch, VP #geneediting therapeutics at Aldevron, in @SEQanswers: https://t.co/IPvUIbiIq4
Big ideas, challenging questions, and meaningful scientific exchange.💥
Our Advanced Genomics Symposium brought together leading voices in genomics to explore the next frontiers of #CRISPR, #AI, and #DNAsynthesis. Thanks to all who joined us in London!🧬
400 institutions served. Up to 50kb. 97% fulfillment. 42x increase in complexity. IDT+@AnsaBio is a partnership that pushes beyond the traditional 7kb synthesis ceiling, and resets standards. Get greater design freedom here: https://t.co/XnnNNHV5nd
If you registered with IDT for the @iGEM Competition, you have until October 12 to order with us! Be sure to snag your 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products, and take advantage of our free resources: https://t.co/aM3bxOR190
Struggling with difficult-to-maintain #DNAconstructs? 🧬 pStable™ vectors offer a stability-focused approach that helps support propagation of large, repetitive, toxic, and complex sequences while allowing researchers to boost plasmid yield when needed. Read more in our latest blog: https://t.co/4S1BiG0ww7
#DNA #genomics #synbio #syntheticbiology @AnsaBio
📣LAST CALL @iGEM PARTICIPANTS! Tomorrow is the final day to register with IDT! Take advantage of 40kb of gBlocks™ Gene Fragments or equivalent value of IDT products for your project. Learn more: https://t.co/aM3bxOR190
It's the last day of #GEAR26! Don't miss your chance to visit the IDT table to discover our CRISPR portfolio, including our new Cas9 mRNA solution and off-target analysis services. See you soon!
We’re excited to announce that we’re partnering with Aldevron to launch a new S.p. Cas9 mRNA solution—offering researchers and therapeutic developers a game-changing approach to gene editing.🙌 Read more here: https://t.co/UDA9KwIa7Q
Curious about IDT’s on-and-off target analysis services that have been in the news lately? Listen to Ashley Jacobi, director of applications and market development, give an overview of what you can expect when you work with her team to analyze your edits.
Learn more here: https://t.co/okALG2TyIA
Explore the Nature publication on IDT’s UNCOVERseq™ here: https://t.co/LgSk5ulPrY
We’ve made it to Stockholm for #ECP2026! Don’t forget to stop by booth #323 to discover how our Archer™ portfolio supports blood cancer applications like liquid biopsy and hematological malignancy research. See you soon! 👋
As #MRD and #MCED research continue to expand #oncology genomics, preserving and converting rare molecular signals is becoming increasingly important for generating high-quality sequencing data in research applications. Read more from IDT's Scott McCuine here: https://t.co/nU9RnVXcQX
#NGS #oncologyresearch #cancerresearch
The next generation of #MRD and #MCED programs demand unprecedented #DNAcomplexity. Learn more in @todaysclinical on how we're helping researchers overcome synthesis limitations with expanded capabilities designed to support increasingly sophisticated assay designs and accelerate innovation in #cancerresearch: https://t.co/gFxdyg06RH
#GEAR26 is almost here! Remember to visit the IDT table to explore our #CRISPR portfolio, including our new #Cas9 mRNA solution and #off-targetanalysis services. Also, check out posters from IDT scientists to see our CRISPR products in action—details below. Learn more here: https://t.co/grrVrOciVw
ICYMI: We’re expanding our collaboration with @AnsaBio to provide broader global access to long and complex #syntheticDNA through a streamlined ordering experience. Over 400 institutions across 33 countries have benefitted from our partnership so far—see a message from one of our customers below! Learn more: https://t.co/I9oY1jlbKe
As #geneediting advances, comprehensive #off-target detection is becoming increasingly important for guide RNA selection, risk assessment, and therapeutic development. Recent research published in @Nature demonstrated that IDT's UNCOVERseq™ achieved the strongest combined sensitivity and precision among the approaches evaluated, helping identify validated off-target sites that other methods may miss.
Learn more from IDT's Gavin Kurgan: https://t.co/ajFQmhTzAy
We're excited to connect with the #pathology and #moleculardiagnostics community at #ECP2026! Visit our trusted experts at booth #323 to explore our portfolio of blood cancer research solutions and discover how Archer™ technologies support liquid biopsy and hematological malignancy research. Learn more: https://t.co/rwWZyDfKhM
We're excited to be attending GEAR for the first time! There’s a few different ways to connect with us:
👉Visit the IDT table to learn more about our CRISPR portfolio, including our new Cas9 mRNA solution, our off-target analysis services, and more.
👉Stop by our SEVEN posters by IDT scientists! This is your chance to see our CRISPR products in action.
We look forward to meeting you! Learn more here: https://t.co/L03bamj4tI